MedCity News

JULY 3, 2025

Dizal Pharmaceutical’s Zegfrovy is now FDA approved for treating non-small cell lung cancer driven by a particular rare genetic signature. Johnson & Johnson drug Rybrevant already addresses this genetic signature as an earlier line of therapy, but Dizal executives contend their drug offers the potential for better safety and efficacy. The post With FDA Nod in Lung Cancer, Dizal Now Aims to Best a J&J Drug and Succeed Where Takeda Fell Short appeared first on MedCity News.

FDA 258

FDA Safety Pharmaceutical Biopharma 258

pharmaphorum

JULY 3, 2025

Dizal gets US approval for an oral therapy for EGFR exon 20-mutated NSCLC, offering some patients an alternative to J&J's intravenous Rybrevant

Patients 88

Patients 88

MedCity News

JULY 3, 2025

Success with agentic AI won’t come from racing to adopt the flashiest tools. It will come from strategic alignment, understanding where AI can create real value, mitigating risk through thoughtful implementation, and ensuring transparency and oversight at every step. The post From Hype to Impact: How Pharma Can Use Agentic AI to Drive Efficiency and Trust appeared first on MedCity News.

Pharma 218

Pharma Pharmaceutical Biopharma 218

European Pharmaceutical Review

JULY 3, 2025

Embedded as the cornerstone of microbiological quality are processes that have remained the same for over a century, unchanged from their early beginnings. To achieve optimal detectability and considerably lower risk to patients, the traditional sterility test requires a minimum of 14 days of incubation, and sometimes even longer if the test sample renders media turbid and subculturing is required to overcome visual interference.

Medicine 69

Medicine Manufacturing Electronics Pharmaceutical manufacturing 69

Advertiser: ZoomInfo

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

Sales

MedCity News

JULY 3, 2025

It became clear to me that if my father’s life could be drastically improved with routine at-home care, so could many others. The next frontier in healthcare isn’t just about new medications or diagnostic tools; it’s about reimagining how and where we deploy our existing clinical expertise. The post What Administering My Father’s Home Infusions for 10 Years Taught Me About Improving Chronic Illness Care appeared first on MedCity News.

Healthcare 272

Healthcare Healthcare Medical Patients 272

pharmaphorum

JULY 3, 2025

Is AstraZeneca about to join the ranks of pharma companies spending big bucks on PD(L)-1xVEGF bispecific antibodies for cancer?

Pharma 71

Pharma 71

pharmaphorum

JULY 3, 2025

Colorectal cancer patients could soon have access via the NHS to a targeted oral drug that can give them more precious time with their loved ones

Patients 65

Patients 65

MedCity News

JULY 3, 2025

But where do truth and trust originate in healthcare marketing? They emerge from various sources such as digital advertising, educational campaigns, patient journeys, and partnerships with healthcare providers who uphold truth in advertising standards. The post From Magic Bullets to Medical Insights: How RFK Jr.’s Critique Shapes the Future of Pharma Advertising appeared first on MedCity News.

Medical 165

Medical Pharma Healthcare Provider Education 165

European Pharmaceutical Review

JULY 3, 2025

New data from an ongoing study shows that a synthetic adeno-associated virus (AAV)-based gene therapy can improve hearing in individuals with congenital condition autosomal recessive deafness 9. It evaluated ten participants aged between one and 24 years old with a genetic form of deafness or severe hearing impairment caused by OTOF gene mutations. This results in otoferlin deficiency, a protein with a key role in transmitting auditory signals from the ear to the brain.

Consulting 52

Consulting Medicine Patients Pharmaceutical 52

MedCity News

JULY 3, 2025

[Sponsored] AI-powered threats are overwhelming outdated IT defenses. Discover why email remains healthcare’s biggest cybersecurity vulnerability and what can be done to address it. The post AI-Driven Email Attacks Are Exploding. Is Your Healthcare Organization at Risk? appeared first on MedCity News.

Healthcare 130

Healthcare Healthcare 130

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

Sales

pharmaphorum

JULY 3, 2025

Novartis hopes of bringing Cosentyx to patients with giant cell arteritis seem to be over after the drug missed all the endpoints in a phase 3 trial.

Patients 58

Patients 58

MedCity News

JULY 3, 2025

Now is the time for senior living leaders to act and re-imagine what resident-centered, modern care can look like, today and in the future. The post AI Is No Longer Optional in Senior Living – Here’s Why appeared first on MedCity News.

165

165

PM360

JULY 3, 2025

There are two schools of thought: one sees AI as a force multiplier for societal good, and the other envisions a doomsday scenario. Do you foresee any existential or catastrophic AI risk? If so, how so? Let me begin with a confession: it is becoming increasingly challenging to keep up with the rapid flow of experimentation, innovation, and research results emerging around large language models (LLMs), which are the basis for Generative AI.

Food and Drug Administration 52

Food and Drug Administration Marketing FDA Pharmaceutical 52

Pharmaceutical Commerce

JULY 3, 2025

Bruce Leuchter, CEO, Neurvati, discusses why patient engagement is essential to understanding rare diseases and driving the development of breakthrough therapies.

Patients 52

Patients 52

Advertiser: ZoomInfo

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

Marketing

PM360

JULY 3, 2025

MIAMI – 30 JUNE, 2025 – PharmaForceIQ has announced a period of significant growth as it goes beyond omnichannel to optichannel campaign solutions. The company is the fastest growing independent provider of precision customer engagement technologies for the Life Science industry, and it has experienced a multifold increase in average contract value in the past year.

Healthcare Provider 52

Healthcare Provider Marketing Healthcare Leads 52

Pharmaceutical Commerce

JULY 3, 2025

The company joins a wave of global pharma companies reshoring operations to strengthen the US supply chain and meet patient needs through domestic innovation and capacity.

Manufacturing 52

Manufacturing Pharma Patients 52

PM360

JULY 3, 2025

Darren Brandt, CEO of Sloane & Company , is a veteran communications strategist with more than 30 years of experience helping companies navigate media relations, corporate positioning, and critical transitions—particularly in the healthcare, financial services, and technology sectors. In this interview, Darren shares insights on his recent transition to sole CEO, the leadership principles shaping Sloane’s culture, and how the firm is adapting to a rapidly evolving PR landscape.

Marketing 52

Marketing Pharma Healthcare Leads 52

pharmaphorum

JULY 3, 2025

On patient-centric treatment decisions and the value of quantitative methodologies, in conversation with Marc Buyse Nicole.

Patients 52

Patients 52

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

Sales

Pharmacy Times

JULY 3, 2025

An expert discusses how the 5 FDA-approved pneumococcal vaccines differ, with newer conjugate vaccines like PCV20 and PCV21 offering broader serotype coverage and better immune memory compared with the older polysaccharide vaccine, though geographic factors may influence vaccine selection.

FDA 26

FDA 26

Pharmaceutical Technology

JULY 3, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Leads 59

Leads Media Government Pharmaceutical 59

Pharmacy Times

JULY 3, 2025

An expert discusses how pharmacists should follow CDC immunization schedules for different age groups and use shared clinical decision-making for patients with prior vaccination history, while considering contraindications primarily related to severe allergic reactions to vaccine components.

Patients 26

Patients 26

Pharmaceutical Technology

JULY 3, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Food and Drug Administration 59

Food and Drug Administration Biopharma Sales process Media 59

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

Pharmacy Times

JULY 3, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Management 26

Management Retail Education Patients 26

Pharmaceutical Technology

JULY 3, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Patients 64

Patients Government Media Pharmaceutical 64

Pharmacy Times

JULY 3, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Prescription 26

Prescription FDA Retail Management 26

Pharmaceutical Technology

JULY 3, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

FDA 52

FDA Food and Drug Administration Media Marketing 52

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

World of DTC Marketing

JULY 3, 2025

A recently leaked memo, allegedly summarizing a high-level meeting of a major biotech industry trade group, has sparked controversy by labeling Health Secretary Robert F. Kennedy Jr. as a “direct threat to public health” due to his stance on vaccines. The memo, whose authenticity remains disputed, exposes deep tensions between the biotech sector and Kennedy, whose skeptical views on vaccines have drawn criticism from medical experts and industry leaders alike.

Government 186

Government Medical Marketing 186

Pharmaceutical Technology

JULY 3, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Food and Drug Administration 52

Food and Drug Administration Media Pharmaceutical Government 52

Pharmacy Times

JULY 3, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Retail 32

Retail Management Education Consulting 32

Pharmaceutical Technology

JULY 3, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

FDA 52

FDA Food and Drug Administration Media Government 52

Advertiser: ZoomInfo

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

Sales Strategy